Clinical Review of Hypertensive Acute Heart Failure
Preprint
- 6 December 2023
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Although acute heart failure (AHF) is a common disease associated with significant symptoms, morbidity and mortality, the diagnosis, risk stratification and treatment of patients with hypertensive acute heart failure (H-AHF) still remain a challenge in modern medicine. Despite great progress in diagnostic and therapeutic modalities, this disease is still accompanied by a high rate of both in-hospital (from 3.8% to 11%) and one-year mortality (from 20% to 36%). Considering the high rate of re-hospitalization (22% to 30% in the first three months), the treatment of this disease represents a major financial blow to the health system of each country. This disease is characterized by heterogeneity in precipitating factors, clinical presentation, therapeutic modalities and prognosis. Since heart decompensation usually occurs quickly (within a few hours) in patients with H-AHF, establishing a rapid diagnosis is of vital importance. In addition to establishing the diagnosis of heart failure itself, it is necessary to see the underlying cause that led to it, especially if it is de novo heart failure. Given that hypertension is a precipitating factor of AHF and in up to 11% of AHF patients, strict control of arterial blood pressure is necessary until target values are reached in order to prevent the occurrence of H-AHF, which is still accompanied by a high rate of both early and long-term mortality.Keywords
All Related Versions
- Version 1, 2023-12-06, Preprints
- Published version: Medicina, 60 (1), 133.
This publication has 116 references indexed in Scilit:
- ‘Time is Prognosis’ in Heart Failure: Time-to-Treatment Initiation as a Modifiable Risk FactorESC Heart Failure, 2021
- In-Hospital and Long-Term Mortality for Acute Heart Failure: Analysis at the Time of Admission to the Emergency DepartmentESC Heart Failure, 2020
- Departments Involved During the First Episode of Acute Heart Failure and Subsequent Emergency Department Revisits and Rehospitalisations: An Outlook Through the NOVICA CohortEuropean Journal of Heart Failure, 2019
- Clinical Phenotypes of Acute Heart Failure Based on Signs and Symptoms of Perfusion and Congestion at Emergency Department Presentation and their Relationship with Patient Management and OutcomesEuropean Journal of Heart Failure, 2019
- Acute Heart Failure Congestion and Perfusion Status – Impact of the Clinical Classification on in-Hospital and Long-Term Outcomes; Insights from the ESC-EORP-HFA Heart Failure Long-Term RegistryEuropean Journal of Heart Failure, 2019
- Patterns of Dyspnoea Onset in Patients with Acute Heart Failure: Clinical and Prognostic ImplicationsESC Heart Failure, 2018
- Non-invasive positive pressure ventilation (CPAP or bilevel NPPV) for cardiogenic pulmonary oedemaCochrane Database of Systematic Reviews, 2013
- Systolic Blood Pressure at Admission, Clinical Characteristics, and Outcomes in Patients Hospitalized With Acute Heart FailureJAMA, 2006
- Noninvasive Ventilation in Acute Cardiogenic Pulmonary EdemaJAMA, 2005
- Intravenous Nesiritide vs Nitroglycerin for Treatment of Decompensated Congestive Heart FailureJAMA, 2002